06:47 AM EDT, 05/03/2024 (MT Newswires) -- Amneal Pharmaceuticals ( AMRX ) reported Q1 adjusted earnings Friday of $0.14 per diluted share, up from $0.12 a year earlier.

Analysts polled by Capital IQ estimated $0.09.

Net revenue for the quarter ended March 31 was $659.2 million, up from $557.5 million a year earlier. The Cap IQ consensus was for $619 million.

The company continues to expect 2024 adjusted diluted EPS of $0.53 to $0.63 on revenue of $2.55 billion to $2.65 billion.

Analysts expect earnings of $0.58 on revenue of $2.60 billion.

Price: 6.35, Change: +0.14, Percent Change: +2.25